AFRIVAX GHANA builds resilient manufacturing ecosystems that bring critical biologics closer to the communities that need them. Our AdCEV® platform enables distributed production with minimal infrastructure and reduced cold chain requirements.

Manufacturing Capabilities

  • GLP/GMP production of clinical products using AdCEV®/Egg expression
  • Recombinant protein design, expression, and purification
  • Custom vaccine antigen development
  • Process scale-up using modular micro-production sites
  • Tech transfer, validation, and documentation support

AdCEV® Platform Advantages

Our proprietary platform leverages fertilized eggs as bioreactors, enabling rapid response manufacturing with lower capital costs, flexible batch sizes, and simplified infrastructure needs.

Schedule a Manufacturing Review
Manufacturing services at AFRIVAX GHANA

Bring production closer to patients

Partner with AFRIVAX GHANA to design efficient, scalable manufacturing strategies.